Atlas FDA

ENZYGNOST F+2 (MONOCLONAL) TEST KIT

FDA 510(k) clearance K042687 · decided 2004-12-10

Clearance details

K-number
K042687
Device name
ENZYGNOST F+2 (MONOCLONAL) TEST KIT
Applicant
Dade Behring, Inc.
Decision
Substantially Equivalent
Date received
2004-09-29
Decision date
2004-12-10
Days to decision
72 days
Clearance type
Traditional
Product code
MIF
Device class
2
Regulation number
864.7320
Medical specialty
Hematology
Advisory committee
Hematology
Location
Newark, DE, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Dade Behring

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
THROMBONOSTIKA F1.2 (K964934)Organon Teknika Corp.1997-03-18
TPP (K962176)Panbio, Inc.1996-10-18
ENZYGNOST F 1+2 (K922934)Behring Diagnostics, Inc.1992-11-16
DADE(R) PROTHROMBIN FRAGMENT F1.2 ELISA (K920895)Baxter Diagnostics, Inc.1992-06-04
THROMBONOSTIKA F1.2 (K911434)Organon Teknika Corp.1991-10-31

Recalls involving this device

No recalls on record reference this clearance.

PMA approvals by this applicant

RecordFirmDate
COBAS INTEGRA 400 PLUS CYCLOSPORINE (P920031/S003)Dade Behring, Inc.2002-07-24
COBAS INTEGRA CYCLOSPORINE (P920031/S002)Dade Behring, Inc.2002-02-26
EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY (P920031/S001)Dade Behring, Inc.2000-08-11
EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY (P920031)Dade Behring, Inc.1996-10-02